Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-02 09:29 am Sale |
2023-12-31 | 13G | AxoGen, Inc. AXGN |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,595,815 6.000% |
-945,483![]() (-26.70%) |
Filing History |
2024-01-26 4:15 pm Purchase |
2024-01-23 | 13G | CalciMedica, Inc. CALC |
SOLEUS CAPITAL MASTER FUND, L.P. | 783,904 7.400% |
783,904![]() (New Position) |
Filing History |
2023-11-28 4:52 pm Purchase |
2023-11-27 | 13D | Theratechnologies Inc. THTX |
SOLEUS CAPITAL MASTER FUND, L.P. | 5,188,876 10.500% |
5,188,876![]() (New Position) |
Filing History |
2023-11-02 4:15 pm Purchase |
2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE |
SOLEUS CAPITAL MASTER FUND, L.P. | 890,868 6.400% |
890,868![]() (New Position) |
Filing History |
2023-08-16 4:30 pm Purchase |
2023-08-15 | 13G | Delcath Systems, Inc. DCTH |
SOLEUS CAPITAL MASTER FUND, L.P. | 806,420 5.300% |
806,420![]() (New Position) |
Filing History |
2023-08-11 4:31 pm Purchase |
2023-08-08 | 13G | AxoGen, Inc. AXGN |
SOLEUS CAPITAL MASTER FUND, L.P. | 3,541,298 8.200% |
3,541,298![]() (New Position) |
Filing History |
2023-07-27 4:30 pm Purchase |
2023-07-26 | 13G | Verastem, Inc. VSTM |
SOLEUS CAPITAL MASTER FUND, L.P. | 1,297,369 5.100% |
1,297,369![]() (New Position) |
Filing History |
2023-04-14 5:07 pm Purchase |
2023-04-13 | 13G | C4 Therapeutics, Inc. CCCC |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,462,020 5.000% |
2,462,020![]() (New Position) |
Filing History |
2023-02-22 4:03 pm Purchase |
2023-02-21 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
SOLEUS CAPITAL MASTER FUND, L.P. | 922,302 5.300% |
922,302![]() (New Position) |
Filing History |
2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
SOLEUS CAPITAL MASTER FUND, L.P. | 7,363,063 5.600% |
737,000![]() (+11.12%) |
Filing History |
2023-02-14 08:19 am Purchase |
2022-12-31 | 13G | Edap Tms S.a. EDAP |
SOLEUS CAPITAL MASTER FUND, L.P. | 5,134,430 14.000% |
244,685![]() (+5.00%) |
Filing History |
2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | IRadimed Corporation IRMD |
SOLEUS CAPITAL MASTER FUND, L.P. | 745,004 5.900% |
98,593![]() (+15.25%) |
Filing History |
2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | Surmodics, Inc. SRDX |
SOLEUS CAPITAL MASTER FUND, L.P. | 775,311 5.500% |
61,347![]() (+8.59%) |
Filing History |
2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Theratechnologies Inc. THTX |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,587,281 10.700% |
168,304![]() (+6.96%) |
Filing History |
2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
SOLEUS CAPITAL MASTER FUND, L.P. | 0 0.000% |
-2,295,100![]() (Position Closed) |
Filing History |
2023-02-14 08:09 am Sale |
2022-12-31 | 13G | CVRx, Inc. CVRX |
SOLEUS CAPITAL MASTER FUND, L.P. | 1,014,640 4.900% |
-29,400![]() (-2.82%) |
Filing History |
2023-02-14 08:06 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
SOLEUS CAPITAL MASTER FUND, L.P. | 0 0.000% |
-498,279![]() (Position Closed) |
Filing History |
2023-02-14 08:00 am Purchase |
2022-12-31 | 13G | Celcuity Inc. CELC |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,285,554 9.900% |
1,337,165![]() (+140.99%) |
Filing History |
2023-01-30 5:01 pm Purchase |
2023-01-27 | 13G | Jasper Therapeutics, Inc. JSPR |
SOLEUS CAPITAL MASTER FUND, L.P. | 625,000 5.700% |
625,000![]() (New Position) |
Filing History |
2023-01-27 5:02 pm Purchase |
2023-01-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
SOLEUS CAPITAL MASTER FUND, L.P. | 50,000 5.400% |
37,500![]() (+300.00%) |
Filing History |